Robert M. Murphy
Keine laufenden Positionen mehr
Karriereverlauf von Robert M. Murphy
Ehemalige bekannte Positionen von Robert M. Murphy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
LAB International, Inc.
 LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Direktor/Vorstandsmitglied | - | 13.07.2007 |
| Corporate Officer/Principal | - | 13.07.2007 | |
| Präsident | - | 13.07.2007 |
Statistik
International
| Kanada | 2 |
Operativ
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
| President | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Health Technology |
- Börse
- Insiders
- Robert M. Murphy
- Erfahrung
